Intuitive Surgical (ISRG) experienced a 5.12% plummet during Friday's intraday trading session, underperforming the broader market as the company's slower procedure growth forecast for 2025 weighed on investor sentiment.
The medical technology company reported better-than-expected earnings and revenue for the fourth quarter, driven by strong sales of its da Vinci surgical robots. However, Intuitive Surgical's outlook for 2025 worldwide da Vinci procedure growth of 13% to 16% fell short of the 17% increase witnessed in the previous year, sparking concerns among investors.
Analysts noted that while the guidance was conservative, in line with Intuitive Surgical's typical approach, the slower projected growth rate compared to 2024 contributed to the stock's sell-off. Traders were skeptical about the company's ability to sustain its momentum, given the potential headwinds in certain market segments and the competitive landscape.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。